Investing.com -- GSK plc (LON: GSK ), a U.K.-based pharmaceutical company, said on Monday that its Blenrep combinations have been approved by Japan’s Ministry of Health. This approval is for the ...

Read More »

Japonia zatwierdza kombinacje leku Blenrep firmy GSK w leczeniu szpiczaka mnogiego

Investing.com — GSK plc (LON: GSK ), brytyjska firma farmaceutyczna, poinformowała w poniedziałek, że kombinacje jej leku Blenrep zostały zatwierdzone przez Ministerstwo Zdrowia Japonii.

Read More »

GSK to acquire new liver disease treatment

GSK plc (LSE/NYSE:LON:GSK) has announced the acquisition of efimosfermin alfa, a promising treatment for steatotic liver disease (SLD), from Boston Pharmaceuticals. The deal, which includes an upfront ...

Read More »

Should I buy the most popular FTSE 100 stock on AJ Bell?

Our writer can see the appeal of this recently popular dividend stock from the FTSE 100 index. But will he buy it for his own ISA?

Read More »

GSK and iTeos end belrestotug antibody program

LONDON - GSK plc (LSE/NYSE:LON:GSK), in collaboration with iTeos Therapeutics, Inc., announced today the termination of their joint development program for belrestotug, an investigational anti-TIGIT ...

Read More »